Valuation: Merck KGaA

Market Cap 65.91B 73.13B 60.89B 55.05B 104B 6,859B 107B 730B 291B 3,673B 274B 269B 11,690B P/E 2026 *
24.1x
P/E 2027 * 21.4x
Enterprise Value 75.11B 83.33B 69.39B 62.73B 119B 7,816B 122B 832B 331B 4,186B 313B 306B 13,321B EV / Sales 2026 *
3.51x
EV / Sales 2027 * 3.16x
Free-Float
29.73%
Yield 2026 *
1.72%
Yield 2027 * 1.59%
1 day-2.42%
1 week-1.36%
Current month-1.98%
1 month+6.96%
3 months+5.93%
6 months+31.24%
Current year+20.96%
1 week 144
Extreme 144
156.25
1 month 137.4
Extreme 137.4
156.25
Current year 100.7
Extreme 100.7
156.25
1 year 100.7
Extreme 100.7
156.25
3 years 100.7
Extreme 100.7
177
5 years 100.7
Extreme 100.7
231.5
10 years 74.54
Extreme 74.54
231.5
Manager TitleAgeSince
Chief Executive Officer 61 01/05/2026
Director of Finance/CFO 56 01/07/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 26/04/2019
Director/Board Member 60 09/05/2014
Director/Board Member 50 28/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
25/03/26 Buy

Chief Executive Officer

3,386 0.0026%
25/03/26 Buy

Chief Financial Officer

4,563 0.0035%
27/03/25 Buy 1,401 0.0011%
Change 5-day change 1-year change 3-year change Capi.($)
-2.47%-1.36%+28.18%-1.59% 73.13B
+0.61%+5.90%+42.00%+135.87% 1,280B
+1.02%+4.08%+45.80%+91.98% 675B
+0.41%+2.86%+27.12%+113.85% 521B
+1.16%+3.83%+40.05%+70.35% 386B
+0.31%+0.48%+61.44%+44.08% 363B
+1.12%+0.04%+28.16%+58.57% 301B
+0.40%-0.58%+3.27%+36.22% 286B
+0.41%+2.07%+39.70%+76.15% 253B
+0.31%+1.62%+37.99%+127.25% 211B
Average +0.33%-0.39%+35.37%+75.27% 435B
Weighted average by Cap. +0.61%+0.21%+38.19%+94.84%

Financials

2026 *2027 *
Net sales 21.39B 23.73B 19.76B 17.87B 33.8B 2,226B 34.64B 237B 94.4B 1,192B 89.07B 87.18B 3,794B 22.69B 25.17B 20.96B 18.95B 35.85B 2,361B 36.73B 251B 100B 1,264B 94.46B 92.45B 4,023B
Net income 2.73B 3.03B 2.52B 2.28B 4.31B 284B 4.42B 30.23B 12.05B 152B 11.37B 11.13B 484B 3.03B 3.36B 2.8B 2.53B 4.79B 315B 4.9B 33.54B 13.37B 169B 12.61B 12.34B 537B
Net Debt 9.2B 10.2B 8.5B 7.68B 14.53B 957B 14.89B 102B 40.58B 512B 38.29B 37.47B 1,631B 5.78B 6.41B 5.34B 4.83B 9.13B 601B 9.35B 63.97B 25.5B 322B 24.06B 23.55B 1,025B
Projected Income Statement - Annual - Merck KGaA
Logo Merck KGaA
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (42.6%); - pharmaceutical products (40.8%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (16.6%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Switzerland (1.9%), Europe (23.7%), the United States (24.8%), North America (1.3%), China (13.7%), Asia/Pacific (19.2%), Latin America (6.9%), Middle East and Africa (3.7%).
Employees
62,136
Date Price Change Volume
12/11/26 €148.30 -2.18% 262,360
11/11/26 €151.60 +1.51% 216,372
10/11/26 €149.35 +0.10% 277,215
09/11/26 €149.20 +0.30% 255,596
06/11/26 €148.75 -1.06% 268,959
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Merck KGaA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
151.60EUR
Average target price
156.23EUR
Spread / Average Target
+3.05%